Steven P. Fling

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Nature Communications(2021)10.1038/s41467-021-26974-6

N/A

4.0DataRank · unranked

227 citations

Magdalena Matusiak, Belén Rivero‐Gutiérrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang +13 more

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy

Science Translational Medicine(2022)10.1126/scitranslmed.abl3836

N/A

2.0DataRank · unranked

103 citations

Scott V. Adams, Rémi Fromentin, Michael Roche, Steven P. Fling, Priscila Gonçalves +19 more

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma

Journal of Clinical Oncology(2024)10.1200/jco.24.00640

N/A

0.592DataRank · unranked

22 citations

Ramya Ramaswami, Irene Ekwede, Vanessa Eulo, Gaurav Goyal, Manoj Menon +22 more

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010291

N/A

0.401DataRank · unranked

10 citations

Angela Shaulov Kask, Leonard D’Amico, Manoj Menon, Kathryn Lurain, Robert Yarchoan +13 more

Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf117

N/A

0.208DataRank · unranked

3 citations

Stuart A. Grossman, Angela Shaulov Kask, Samuel Kosydar, Roy E. Strowd, Anna F. Piotrowski +12 more

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

Frontiers in Oncology(2023)10.3389/fonc.2023.1168710

N/A

0DataRank · unranked

5 citations

Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Rachel A. Lundeen, Ulianna Voytovich +24 more

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1728

N/A

0DataRank · unranked

7 citations

Gurkamal Chatta, Rohit K. Jain, Helen Moon, Scott E. Delacroix, Alana Fang +10 more

Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101390

N/A

0DataRank · unranked

18 citations

Timothy Bi, Thomas H. Pulliam, Korok Sarkar, Candice D. Church, Nandita Kumar +10 more

T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci177082

N/A

0DataRank · unranked

15 citations

Candice D. Church, Ana Micaela Carnaz Simões, Marcus Svensson, Amalie Kai Bentzen, Siri Tvingsholm +7 more

Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101527

N/A

0DataRank · unranked

9 citations

Koshlan Mayer-Blackwell, Nirasha Ramchurren, K. Rachael Parks, George E. Durán, Anna K. Wright +7 more

Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome

medRxiv(2022)10.1101/2022.03.29.22272994

N/A

0DataRank · unranked

0 citations

Nirasha Ramchurren, Steven P. Fling, Youn H. Kim, Michael S. Khodadoust, Tianying Su

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002903

N/A

0DataRank · unranked

67 citations

Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard J. Appleman, Paul Monk +18 more

New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy

Patterns(2021)10.1016/j.patter.2021.100372

N/A

0DataRank · unranked

43 citations

Greg Finak, Leonard D’Amico, Nina Bhardwaj, Candice D. Church, Chihiro Morishima +7 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Research Square(2021)10.21203/rs.3.rs-122285/v1

N/A

0DataRank · unranked

6 citations

Darci J. Phillips, Magdalena Matusiak, Belén Gutiérrez‐Gutiérrez, Salil S. Bhate, Graham L. Barlow +13 more

Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005128

N/A

0DataRank · unranked

13 citations

Kathryn Lurain, Julius Strauss, Steven P. Fling, Elad Sharon, Anna K. Wright +8 more

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

medRxiv(2020)10.1101/2020.12.06.20244913

N/A

0DataRank · unranked

19 citations

Magdalena Matusiak, Belén Rivero‐Gutiérrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang +13 more